Abstract
The application of non-bioartificial liver system in treating liver failure patients has been investigated for decades, and gradually accepted as an alternative therapy for patients with liver failure. Due to the development of blood purification technology, several of the non-bioartificial liver systems including Li’s non-bioartificial liver system (Li-NBAL), molecular adsorbents recirculating system (MARS™), plasma separation and absorption system (Prometheus™) have been developed and widely studied, both in animal experiments and in clinical trials. In this chapter, we introduce different methods of blood purification and different filters and absorbents, which are used by each method. Then we introduce their application on the treatment of patients with liver failure and our clinical experience of Li-NBAL.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Saliba F, Camus C, Durand F, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med. 2013;159(8):522–31.
Bañares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57(3):1153–62.
Li LJ, Liu XL, Xu XW, et al. Comparison of plasma exchange with different membrane pore sizes in the treatment of severe viral hepatitis. Ther Apher Dial. 2005;9(5):396–401.
Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64(1):69–78.
Yue-Meng W, Yang LH, Yang JH, et al. The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure. Hepatol Int. 2016;10(3):462–9.
Ling Q, Xu X, Wei Q, et al. Artificial liver support system combined with liver transplant in the treatment of patients with acute-on-chronic liver failure. PLoS One. 2013;8(3):e58738.
Ide K, Muguruma T, Shinohara M, et al. Continuous veno-venous hemodiafiltration and plasma exchange in infantile acute liver failure. Pediatr Crit Care Med. 2015;16(8):e268–74.
Ye WJ, Li LJ, Yu HY, et al. Clinical research of plasma exchange with continuous veno-venous hemofiltration in treating mid- and late-stage chronic severe viral hepatitis B patients. Zhonghua Gan Zang Bing Za Zhi. 2005;13(5):370–3.
Liu X, Zhang Y, Xu X, et al. Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study. Ther Apher Dial. 2015;19(2):178–84.
Cutuli SL, Artigas A, Fumagalli R, et al. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry. Ann Intensive Care. 2016;6(1):77.
Nakae H, Igarashi T, Tajimi K, et al. A case report of hepatorenal syndrome treated with plasma diafiltration (selective plasma filtration with dialysis). Ther Apher Dial. 2007;11(5):391–5.
Nakae H, Eguchi Y, Saotome T, et al. Multicenter study of plasma diafiltration in patients with acute liver failure. Ther Apher Dial. 2010;14(5):444–50.
Zhou N, Li J, Zhang Y, et al. Efficacy of coupled low-volume plasma exchange with plasma filtration adsorption in treating pigs with acute liver failure: a randomised study. J Hepatol. 2015;63(2):378–87.
Mitzner SR. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS). Ann Hepatol. 2011;10(Suppl 1):S21–8.
Vaid A, Chweich H, Balk EM, et al. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J. 2012;58(1):51–9.
Saliba F, Camus C, Durand F, et al. Albumin dialysis with a non-cell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med. 2013;159(8):522–31.
Marangoni R, Bellati G, Castelli A, et al. Development of the high-efficiency molecular adsorbent recirculating system: preliminary report. Artif Organs. 2014;38(10):879–83.
Dyla A, Mielnicki W, Bartczak J, et al. Effectiveness and safety assessment of citrate anticoagulation during albumin dialysis in comparison to other methods of anticoagulation. Artif Organs. 2017;41(9):818–26.
Falkenhagen D, Strobl W, Vogt G, et al. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin-bound substances. Artif Organs. 1999;23:81–6.
Santoro A, Faenza S, Mancini E, et al. Prometheus system: a technological support in liver failure. Transplant Proc. 2006;38(4):1078–82.
Grodzicki M, Kotulski M, Leonowicz D, et al. Results of the treatment of acute liver failure patients with the use of the prometheus FPSA system. Transplant Proc. 2009;41(8):3079–81.
Kribben A, Gerken G, Haag S, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142(4):782–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd. and Zhejiang University Press
About this chapter
Cite this chapter
Xie, Z., Zhao, Y., Zhu, D., Xu, X., Yang, Q., Li, L. (2021). Non-bioartificial Liver. In: Li, L. (eds) Artificial Liver. Springer, Singapore. https://doi.org/10.1007/978-981-15-5984-6_13
Download citation
DOI: https://doi.org/10.1007/978-981-15-5984-6_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-5983-9
Online ISBN: 978-981-15-5984-6
eBook Packages: MedicineMedicine (R0)